Roxane Ridolfo

Roxane Ridolfo is a Research and Innovation Scientist at MedinCell since April 2021, focusing on optimizing BEPO® technology for long-acting injectables. Prior experience includes a role at RedLab Paris, where Roxane developed an innovative online diagnostic tool integrating pharmaceutical and cosmetic knowledge. A PhD in Nanomedicine and Drug Delivery was completed at TU/e Eindhoven University of Technology, resulting in five publications and two patents, with a focus on ocular drug delivery. Roxane’s research experience spans several prestigious institutions, including the University of Helsinki and Imperial College London, where studies involved polymeric nanoparticles for drug delivery applications. Educational background includes studying at Ensmac and the Ecole nationale supérieure de Chimie de Rennes, laying a strong foundation in chemical sciences.